Celularity Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: CELUW · Form: 8-K · Filed: Aug 1, 2025 · CIK: 1752828
Sentiment: neutral
Topics: material-agreement, financial-obligation, equity-sale
Related Tickers: CELU
TL;DR
Celularity Inc. filed an 8-K detailing a material agreement, new debt, and equity sales.
AI Summary
On July 21, 2025, Celularity Inc. entered into a material definitive agreement, likely related to its financial obligations. The company also reported on the creation of a direct financial obligation and unregistered sales of equity securities. This filing follows its previous name change from GX Acquisition Corp. in 2018.
Why It Matters
This 8-K filing indicates significant financial activity and potential new obligations for Celularity Inc., which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements, financial obligations, and unregistered equity sales, suggesting potential financial complexities and risks for the company.
Key Players & Entities
- Celularity Inc. (company) — Registrant
- GX Acquisition Corp. (company) — Former Company Name
- July 21, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Celularity Inc. on July 21, 2025?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What type of direct financial obligation was created by Celularity Inc.?
The filing states the creation of a direct financial obligation, but the specific terms and amount are not detailed in the provided text.
What were the circumstances of the unregistered sales of equity securities by Celularity Inc.?
The filing mentions unregistered sales of equity securities, but the details regarding the number of shares, price, and purchasers are not included in the provided text.
When did Celularity Inc. change its name from GX Acquisition Corp.?
Celularity Inc. changed its name from GX Acquisition Corp. on September 12, 2018.
What is Celularity Inc.'s Standard Industrial Classification (SIC) code?
Celularity Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 1, 2025 regarding Celularity Inc (CELUW).